Trials.ai

trials.ai · San Diego, United States of America

Trials.ai is a software company that provides an AI-driven platform to help life sciences organizations design and optimize clinical trial protocols, aiming to improve patient recruitment, reduce amendments, and accelerate study timelines. Its solution analyzes historical trial data and operational constraints to recommend protocol changes and feasibility improvements for sponsors, CROs, and research teams. The company generates revenue through subscription and service-based licensing of its platform to pharmaceutical, biotech, and clinical research organizations.

Revenue
<$10M
Employees
1 - 50
Founded
2016
Headquarters
San Diego, United States of America

Trials.ai customers on Arbolus

Total customers 13 9 current · 4 former
Reviews growth 13 new reviews since Nov 2025

Customers who reviewed Trials.ai

Seniority of Trials.ai customers

The largest group of people who reviewed Trials.ai holds Director roles (46%), followed by C-Suite (38%) and Manager (15%).

  • Director 46%
  • C-Suite 38%
  • Manager 15%

Customers sample

Operations Leader Manager NPS 8
Strategy Leader Director NPS 10 Will renew
Other Leader Manager NPS 10

Employer names and spend open once the report publishes.

What 13 Arbolus experts think of Trials.ai

Overall sentiment: Positive

NPS scores show a strong positive skew: 20% of respondents are promoters (NPS 10), 60% yield scores of 8-9, and none report negative sentiment. Among those with specified renewal intent, 100% express intent to renew; however, notable uncertainty exists among pilot and influencer users. Stickiness is high after one year, with the largest share already in advanced implementation. The overall customer sentiment is buoyed by strong NPS, multi-year stickiness, and high-spend promoter profile.

Tell us when the Trials.ai report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

38 Net Promoter Score, from 13 scored reviews
  • Promoters 5
  • Passives 8
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 2 answers
  • Director 100% 1 answer
  • 10/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Trials.ai

Do you use Trials.ai at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of Trials.ai have already contributed

Takes a few minutes. Your identity stays anonymous.